Suchergebnisse - "Hodroj, Mohammad Hassan"

PubPharm (26)

21

Synergistic Effect of Epigenetic Inhibitors Decitabine and Suberoylanilide Hydroxamic Acid on Colorectal Cancer In vitro

enthalten in: Current molecular pharmacology | 2019

von Abou Najem, S. | Khawaja, G. | Hodroj, M. | +1

22

Synergistic Effect of Epigenetic Inhibitors Decitabine and Suberoylanilide Hydroxamic Acid on Colorectal Cancer In vitro

enthalten in: Current molecular pharmacology | 2019

von Najem, S. | Khawaja, G. | Hodroj, M. | +1

23

Synergistic effect of epigenetic inhibitors decitabine and suberoylanilide hydroxamic acid on colorectal cancer in vitro

enthalten in: The FASEB Journal | 2019

von Rizk, S. | Najem, S. | Hodroj, M. | +1

24

Andrographolide potentiates the antitumor effect of topotecan in acute myeloid leukemia cells through an intrinsic apoptotic pathway

enthalten in: Cancer management and research | 2018

von Hodroj, M. | Jardaly, A. | Abi Raad, S. | +2

25

Thymoquinone from Nigella sativa Seeds Promotes the Antitumor Activity of Noncytotoxic Doses of Topotecan in Human Colorectal Cancer Cells in Vitro

enthalten in: Planta medica | 2016

von Khalife, R. | Hodroj, M. | Fakhoury, R. | +1

26

Antiproliferative and proapoptotic effects of topotecan in combination with thymoquinone on acute myelogenous leukemia

enthalten in: Clinical lymphoma, myeloma & leukemia | 2014

von Khalife, R. | El-Hayek, S. | Stephany, E. | +3

ErratumIn: Clin Lymphoma Myeloma Leuk. 2015 Jun;15(6):384 Stephany, El-Hayek [corrected to El-Hayek, Stephany]